MSN: Researchers study how immunotherapy affects COVID-19 outcomes
MSN highlighted recent research from the University of Cincinnati Cancer Center on how immunotherapy treatments and immunosuppression affects the severity of COVID-19 infections for patients with cancer.
Trisha Wise-Draper, MD, PhD, co-led the research that was recently published in JAMA Oncology.
"We reviewed patients with cancer, those that had baseline immunosuppression, and those that were treated with immunotherapy prior to getting COVID-19," said Wise-Draper, associate professor of medicine in the Division of Hematology/Oncology, section head for Medical Oncology in UC’s College of Medicine, Head and Neck Center of Excellence co-leader and a UC Health physician. "The most important finding is that although those treated with immunotherapy alone did not have an effect on COVID-19 disease outcomes, those that had baseline immunosuppression and were treated with immunotherapy had worse outcomes with COVID-19."
Related Stories
High Court offers protections for therapy speech
April 5, 2026
Jennifer Bard, a professor in the Donald P. Klekamp College of Law and the UC Department of Internal Medicine, spoke with journalists about the US Supreme Court ruling granting first amendment protections for speech offered during therapy sessions.
Scientists discover how snakes stand upright without limbs
April 3, 2026
Smithsonian magazine highlights a study co-authored by UC Professor Bruce Jayne, an expert in snake locomotion, about how snakes stand upright without arms or legs.
On track: Hoffman Honors Scholar studies public transit
April 2, 2026
Public transit is where Zane Sawyer’s lifelong passion for travel meets his commitment to making an impact. The University of Cincinnati first-year geography major in the College of Arts & Sciences and member of the second cohort of Hoffman Honors Scholars (HHS) has hit the ground running, designing a research project intended to capture both how public transit works and how its users perceive it.